Clinical Trials Directory

Trials / Completed

CompletedNCT04649840

Estimation of Dynamics of Humoral and Cellular Immunity in COVID-19 Patients

Status
Completed
Phase
Study type
Observational
Enrollment
274 (actual)
Sponsor
Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus · Other Government
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The goal of the project: to study the dynamics of the humoral and cellular immunity in patients after pneumonia caused by the SARS-CoV-2 virus at different time intervals, in order to predict the duration of immune protection

Detailed description

* to form study groups of patients (at least 60 patients in total) who have recovered from pneumonia of varying severity caused by the SARS-CoV-2 virus (at least 30 patients in each of the groups of patients who have had pneumonia in moderate and severe forms); * to investigate the parameters of cellular immunity (the content of antigen-specific T-cells to the main viral antigens - proteins S, N, M) in patients of different groups included in the trials, in dynamics 3, 6, 9 and 12 months after the COVID-19-associated pneumonia; * to investigate the indicators of humoral immunity (the content of IgG to the main viral antigens - proteins S, N, M) in patients of different groups included in the trials, in dynamics 3, 6, 9 and 12 months after the COVID-19-associated pneumonia.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTHumoral and cellular immunityHumoral (IgG) and cellular (antigen-specific cells) immunity

Timeline

Start date
2020-10-01
Primary completion
2021-12-09
Completion
2021-12-09
First posted
2020-12-02
Last updated
2021-12-10

Locations

1 site across 1 country: Belarus

Source: ClinicalTrials.gov record NCT04649840. Inclusion in this directory is not an endorsement.